Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
European Journal of Human Genetics : EJHG
|
July 12, 2012
Adaptive clustering and adaptive weighting methods to detect disease associated rare variants
Qiuying Sha, Shuaicheng Wang, Shuanglin Zhang
Statistics in Medicine
|
April 20, 2018
Subgroups from regression trees with adjustment for prognostic effects and postselection inference
Wei-Yin Loh, Michael Man, Shuaicheng Wang
BMC Proceedings
|
December 19, 2014
Detecting association of rare and common variants by testing an optimally weighted combination of variants with longitudinal data
Shuaicheng Wang, Shurong Fang, Qiuying Sha, et al.
Investigational New Drugs
|
March 7, 2020
Phase 1b/2a study of galunisertib, a small molecule inhibitor of transforming growth factor-beta receptor I, in combination with standard temozolomide-based radiochemotherapy in patients with newly diagnosed malignant glioma
Antje Wick, Annick Desjardins, Cristina Suarez, et al.
The Journal of Applied Laboratory Medicine
|
February 27, 2021
Analytical Characterization of an Enzyme-Linked Immunosorbent Assay for the Measurement of Transforming Growth Factor β1 in Human Plasma
Brendan M Giles, Timothy T Underwood, Karim A Benhadji, et al.
Plos One
|
June 17, 2021
Correction: Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib
Gianluigi Giannelli, Armando Santoro, Robin K Kelley, et al.
Plos One
|
March 27, 2020
Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib
Gianluigi Giannelli, Armando Santoro, Robin K Kelley, et al.
Cancer Chemotherapy and Pharmacology
|
March 20, 2019
TGFβ receptor inhibitor galunisertib is linked to inflammation- and remodeling-related proteins in patients with pancreatic cancer
Davide Melisi, Rocio Garcia-Carbonero, Teresa Macarulla, et al.
The Lancet. Diabetes & Endocrinology
|
December 17, 2022
Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trials
Adem Y Dawed, Andrea Mari, Andrew Brown, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
European Journal of Human Genetics : EJHG
|
July 12, 2012
Adaptive clustering and adaptive weighting methods to detect disease associated rare variants
Qiuying Sha, Shuaicheng Wang, Shuanglin Zhang
Statistics in Medicine
|
April 20, 2018
Subgroups from regression trees with adjustment for prognostic effects and postselection inference
Wei-Yin Loh, Michael Man, Shuaicheng Wang
BMC Proceedings
|
December 19, 2014
Detecting association of rare and common variants by testing an optimally weighted combination of variants with longitudinal data
Shuaicheng Wang, Shurong Fang, Qiuying Sha, et al.
Investigational New Drugs
|
March 7, 2020
Phase 1b/2a study of galunisertib, a small molecule inhibitor of transforming growth factor-beta receptor I, in combination with standard temozolomide-based radiochemotherapy in patients with newly diagnosed malignant glioma
Antje Wick, Annick Desjardins, Cristina Suarez, et al.
The Journal of Applied Laboratory Medicine
|
February 27, 2021
Analytical Characterization of an Enzyme-Linked Immunosorbent Assay for the Measurement of Transforming Growth Factor β1 in Human Plasma
Brendan M Giles, Timothy T Underwood, Karim A Benhadji, et al.
Plos One
|
June 17, 2021
Correction: Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib
Gianluigi Giannelli, Armando Santoro, Robin K Kelley, et al.
Plos One
|
March 27, 2020
Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib
Gianluigi Giannelli, Armando Santoro, Robin K Kelley, et al.
Cancer Chemotherapy and Pharmacology
|
March 20, 2019
TGFβ receptor inhibitor galunisertib is linked to inflammation- and remodeling-related proteins in patients with pancreatic cancer
Davide Melisi, Rocio Garcia-Carbonero, Teresa Macarulla, et al.
The Lancet. Diabetes & Endocrinology
|
December 17, 2022
Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trials
Adem Y Dawed, Andrea Mari, Andrew Brown, et al.
Page
of 1